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 Abstract 
  Background:   With the aging of the population, dementia is increasing worldwide. The objec-
tive of this study was to identify risk factors for dementia in an elderly population utilizing a 
primary health care service in Dakar, Senegal.   Methods:   Through a cross-sectional study con-
ducted from March 2004 to December 31, 2005, 507 elderly patients aged  6 65 years who came 
to the Social and Medical Center of IPRES, Dakar, Senegal, were first screened with the screen-
ing interview questionnaire ‘Aging in Senegal’. Those who were cognitively impaired under-
went a clinical examination to detect dementia. Univariate, bivariate, and multivariate logistic 
regression analyses were done.   Results:   The whole population had a mean age of 72.4 years 
( 8  5.2) and was mostly male, married, and non-educated. Hypertension, arthritis, and gastroin-
testinal diseases were the main health conditions reported in the past medical history. Smoking 
was important while alcohol consumption was rare. Social network was high. Forty-five pa-
tients (8.87%) had dementia. In the multivariate model, only advanced age, education, epilepsy, 
and family history of dementia were independently associated with dementia.  Conclusion:  The 
risk factors identified are also found in developed countries confirming their role in dementia. 
It is important to take dementia into consideration in Senegal and to sensitize the community 
for prevention.    Copyright © 2012 S. Karger AG, Basel 
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 Introduction 
 With the aging of the population worldwide, dementia is a real public health priority  [1] . 
In 2000, the estimated number of dementia cases was 25.5 million people, representing 0.4% 
of the worldwide population. Moreover, 52% of the cases lived in developing countries. This 
number will be 65.7 million in 2030 and 115.4 million in 2050. Nearly two thirds of all peo-
ple with dementia lived in low- and middle-income countries  [2] . Dementia constitutes a real 
social, economic, and medical burden. Its prevalence increases with age   [3]  . The other most 
important risk factors are low level of education  [4] , heredity  [5] , low early-life economic con-
ditions  [6] , smoking  [7] , alcohol  [8] , weak social network  [9] , hypertension  [10] , cardiovascu-
lar diseases   [11]  , stroke   [12]  , epilepsy   [13]  , diabetes   [14]  , anemia   [15]  , Parkinson’s disease   [16]  , 
and head trauma   [17]  .
    Although several population-based studies were conducted in developed countries to 
better understand the epidemiology of this new epidemic, only a few studies have been done 
in Africa   [18]  . In Senegal, the estimated number of elderly aged   6  65 years was 421,305 in 
2008 and 420,795 in 2009. It will be 426,443 in 2012   [19]  . This means that the number of de-
mented elderly will increase also. Considering the economic cost of dementia care, Senegal 
is not able to afford such cost. It is important to have reliable information on the prevalence 
of dementia to plan for more accurate provision of social and medical services for the elder-
ly population. Identifying risk factors helps to plan for prevention programs. Studies on de-
mentia in the Senegalese elderly population are rare   [20, 21]  . Thus, a study was conducted in 
Senegal to determine the epidemiology of dementia in an elderly population utilizing a pri-
mary health care service for retirees in Dakar, Senegal. The aim of the present study was to 
identify risk factors associated with dementia in this population of retirees utilizing the So-
cial and Medical Center (SMC) of IPRES (Institution de Prevoyance Retraite du Senegal), 
Dakar, Senegal.
  M e t h o d s  
 Study  Design 
  The site of the study was the SMC of IPRES. This is a health center for the retired Sen-
egalese elderly population affiliated to IPRES ensuring medical and social services. As a pri-
mary care center with diverse health personnel, it ensures full and free medical coverage to 
the elderly population and their families. A pharmacist offered free medication. 
    The study population was composed of Senegalese elderly patients aged   6  65 years who 
came to the SMC of IPRES for health problems. This population is affiliated to IPRES. Those 
patients who were either   !  65 years old or were not able to fulfill the interview (due to apha-
sia, delirium, coma, extreme visual and auditory impairment, or cancer at terminal phase) 
were excluded.
  The study was cross-sectional. From March 2004 to December 2005, 507 elderly patients 
aged   6  65 years – or their relatives – who consulted a doctor for a medical problem at the 
SMC of IPRES were first assessed with a screening interview questionnaire. Those who were 
cognitively impaired, with a sex-matched sample, underwent a clinical exam with neuropsy-
chological testing. This study was the first step of a research on the validation of a screening 
tool to screen for dementia in a Senegalese elderly population called ‘The Test of Senegal’ 
 [22] .162
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  The  Screening  Instruments 
 Two screening instruments were used: the interview questionnaire called ‘Aging in Sen-
egal’ and the clinical assessment instrument.
    The screening interview questionnaire ‘Aging in Senegal’ contained the following: so-
ciodemographic variables (age, sex, marital status, education), medical history [vascular dis-
eases (hypertension, heart diseases, vascular peripheral disease, stroke, diabetes), respira-
tory diseases, arthritis, cancer/benign tumor, Parkinson’s disease, epilepsy, genitourinary 
disease, cataract, glaucoma, hearing impairment, digestive disease (gastritis, constipation), 
anemia, thyroid disease, head trauma, bone fracture], familial history of memory impair-
ment, lifestyle (smoking, alcohol consumption, walking), social network (social ties with 
spouse, children, brothers/sisters, friends; frequency of weekly contact with children, broth-
ers/sisters, friends; members of community association, member of religious association), the 
patient’s functional autonomy   [23]  , and the neuropsychological tests with the Abbreviated 
Mental Test   [24]   and the Test of Senegal   [25]  . This tool was used by the medical students.
    The clinical assessment instrument had four components: (1) a historical review of the 
patient’s cognitive function, i.e., the onset and progression of any reported symptoms of cog-
nitive impairment; (2) a review of the patient’s medical, surgical, and familial history, expo-
sure to toxic products and medications; (3) a review of the patient’s functional autonomy  [23] , 
and (4) a review of the patient’s clinical exam and neuropsychological testing with the Mini-
Mental State Examination (MMSE)   [26]  . This tool was used by the principal investigator 
(K.T.).
  I n t e r v i e w  
  Each patient underwent a screening interview with the questionnaire ‘Aging in Senegal’ 
by four medical students at the SMC who were trained for this issue. This interview was con-
ducted concomitantly with the informant and the patient. It aimed to collect data related to 
sociodemographics, lifestyle, past medical history, and social network and to screen for neu-
ropsychological performance with the Abbreviated Mental Test. 
  C l i n i c a l   A s s e s s m e n t  
  After the interview, each patient who had a score of   ^  5 on the Abbreviated Mental Test 
 [24]  was referred for clinical assessment to the principal investigator (K.T.). At the same time, 
a sex-matched normal subject was also referred for clinical assessment. The clinical assess-
ment consisted of a complete physical exam followed by a neuropsychological testing with 
the MMSE   [26]  . If a patient was suspected to have depression, the CES-D scale was admin-
istered to him/her to confirm the diagnosis  [27] . All clinical assessments were made without 
knowledge of the screening status of the patient. At the end of the consultation, the team 
members met in a room to confirm the diagnosis of the patient. On the basis of the exami-
nation, patients with dementia were followed by the principal investigator (K.T.). Appropriate 
laboratory exams and computerized tomography of the head were ordered and treatment of 
associated medical conditions proposed. 
  Variables  of  Studies 
  Sociodemographic variables [age in 4 categories (65–69, 70–74, 75–79, and   6 80  years), 
sex, marital status, education] were collected with the medical history and familial history 
of cognitive impairment. Lifestyle was divided into smoking habit (yes, no), alcohol con-
sumption (yes, no), and walking (yes, no).
    For the social network, we computed two indexes: diversities of social ties (score 0–4) 
and frequency of weekly contact with relatives (score 0–6). Diversity of social ties was com-
puted by summing ‘Having a spouse or husband, children, brothers/sisters, and friends’ and 163
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categorized into 3 levels: 0–2 ties, 3 ties, and 4 ties. Frequency of weekly contact with rela-
tives was obtained by summing the frequency of weekly contact with children, brothers/
sisters, and friends and categorized into 4 levels: 0–3 weekly contacts, 4 weekly contacts, 5 
weekly contacts, and 6 weekly contacts. The medical conditions related to medical variables 
were dichotomized into ‘yes or no’. Dementia was defined according to the DSM-IV-R cri-
teria   [27, 28]  .
  Ethical  Consideration 
  This study was approved by the ethical committee of the Senegalese Ministry of Health 
and University of Montreal, Que., Canada. Before the start of the study, oral informed con-
sent was obtained from the patient and/or his/her relative.
  Statistical  Analysis 
  All the data collected were analyzed using the SPSS-13.0 version package for Windows. 
Univariate, bivariate, and multivariate stepwise logistic regression analyses were computed. 
The odd ratios of the different risk factors were computed with a 95% CI.
  R e s u l t s  
 Forty-five patients (8.87%; 95% CI 7.61–10.13) had dementia. The whole population with 
a mean age of 72.4 years (  8  5.2) was mostly male, married, and illiterate. Smoking was im-
portant (27.0%) while alcohol consumption was rare (9.1%). Walking was the main physical 
activity (95.0%). The elderly population had a high diversity of ties and frequency of contact 
with relatives and friends (  table 1  ). Hypertension (58.6%), arthritis (49.5%), gastrointestinal 
diseases (24.1%), respiratory diseases (14.7%), and cataract (14.4%) were the main health con-
ditions reported in the past medical history (  table 2  ).
    In the bivariate analysis, age (p   !   0.045), education (p   !   0.02), diversity of ties with 
relatives (p   !   0.001), frequency of contact with relatives (p   !   0.0001), stroke (p   !   0.002), 
epilepsy (p   !   0.002), and family history of dementia (p   !   0.0001) were associated with de-
mentia.
    In the multivariate model, advanced age (  6  80 years; OR 4.26; 95% CI 1.36–13.3), illit-
eracy (OR 2.76; 95% CI 1.23–6.20), epilepsy (OR 11.72; 95% CI 2.10–65.23), and family his-
tory of dementia (OR 7.56; 95% CI 3.42–16.76) were independently associated with dementia 
( table 3 ).
Variables n %






















Table 1. C  haracteristics of the 
population (n = 507)164
Dement Geriatr Cogn Disord Extra 2012;2:160–168
 DOI:  10.1159/000332022 
  Published online: April 18, 2012 
EXTRA
  Toure et al.: Risk Factors for Dementia in a Senegalese Elderly Population 
www.karger.com/dee
    © 2012 S. Karger AG, Basel
  Discussion 
  In our study, prevalence of dementia was 8.87% with advanced age, illiteracy, epilepsy, 
and family history of dementia as independent risk factors. These risk factors were either 
self-reported by the patient or informant-reported. 
    The role of age as a risk factor for dementia has been highlighted in several studies. In 
fact, the prevalence of dementia is increasing importantly with age as observed in a clinical 
setting and during population studies. Thus, the result we observed confirms the role of age-
ing (especially advanced age) in the occurrence of dementia as described elsewhere in Europe 
  [3, 29–31]  , America   [32–34]  , Asia   [35–37]  , and Africa   [21, 38–41]  .
    Illiteracy was frequent (57%) and was associated with dementia in our elderly popula-
tion. This result confirms the role of illiteracy as a risk factor for dementia in an elderly pop-
ulation as already seen in studies realized worldwide   [42–46]  . 
    Epilepsy in the elderly is frequent, with an estimated prevalence of 1% after 60 years of 
age   [47]   and an incidence increasing with age   [48]  . In our study population, history of epi-
lepsy was present in 1.4% of the elderly and associated with dementia. This finding has been 
observed in several studies conducted worldwide, enhancing the association between a his-




Gastrointestinal disease 122 24.1
Genitourinary disease 82 16.2
Cataract 73 14.4
Respiratory diseases 72 14.2
Anemia 54 10.7
Head trauma 50 9.9
Fracture of the bone 37 7.3
Diabetes 36 7.1
Heart disease 34 6.7
Stroke 23 4.5
Parkinson’s disease  7 1.4
Epilepsy 7 1.4
Glaucoma 7 1.4
Thyroid disease 2 0.4
Familial history of dementia 46 9.1
Table 2.   Medical, surgical, and 
familial past history (n = 507)
Variables OR 95% CI
Age
65–69 years – –
70–74 years 1.92 0.7–5.1
75–79 years 1.96 0.68–5.7
≥80 years 4.26 1.36–13.3
Illiteracy 2.76 1.23–6.20
Epilepsy 11.72 2.10–65.23 
Family history of dementia  7.56 3.42–16.75
Table 3.   Results of the 
multivariate analysis165
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related to the disease itself, its cause or risk factor, but also to the treatment prescribed, espe-
cially in our country, where most of the epileptic patients are on a first-generation anti-epi-
leptic regimen, which is harmful for cognition. Whatever the mechanism, epilepsy is associ-
ated with the occurrence of dementia. 
    Familial history of dementia, which was observed in 9.1% of our study population, has 
been associated with the occurrence of dementia. The role of heredity in dementia is known 
specially for Alzheimer’s disease  [53] . In fact, studies in Australia  [54] , Africa  [55, 56] , Europe 
  [57, 58]  , and the USA   [5]   have demonstrated that familial history of dementia is a main risk 
factor for dementia in an elderly population. Also, ApoE     4 has been associated with Alz-
heimer’s disease in the developed world   [59, 60]  . However, this association is absent in an 
African study  [61] . Genetic mutations are also observed in demented persons at chromosome 
12   [62]   and chromosomes 6, 9, 10, 12, 19, and 21   [63, 64]  .
    Limitations of the study include the underestimation of the prevalence because all the 
demented patients were not recruited during the study period. Medical illnesses were based 
upon self-report or informant report rather than on direct examination. Moreover, memory 
bias could underestimate risk factors and, thus, their role in the occurrence of dementia. 
Also, this study is a prevalence study, not an incidence study, characterized by temporality 
of the association between risk factors and dementia. However, it highlights and confirms 
the role of these risk factors on dementia occurrence in an elderly population.
  Conclusion 
  This study has shown that illiteracy, epilepsy, and familial history of dementia were as-
sociated with dementia in this study population. Additionally, it confirms the role of these 
risk factors in the occurrence of dementia in an elderly population as described elsewhere. 
As the Senegalese population is aging, it is necessary to take dementia into consideration in 
the social, political, and medical practice and to sensitize political leaders, the health person-
nel, and the population for the prevention of this disease. 
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